Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
The Journal of Pharmacology and Experimental Therapeutics|April 23, 2005
Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposureP R Lockman, G McAfee, W J Geldenhuys, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2010
Bis-azaaromatic quaternary ammonium salts as ligands for the blood-brain barrier choline transporterGuangrong Zheng, Zhenfa Zhang, Paul R Lockman, et al.
Brain Research|February 1, 2008
Neuroprotection in mice by NGP1-01 after transient focal brain ischemiaJiukuan Hao, Alexander Mdzinarishvili, Thomas J Abbruscato, et al.
Frontiers in Cellular Neuroscience|March 7, 2019
Extracellular Vesicles Secreted in Response to Cytokine Exposure Increase Mitochondrial Oxygen Consumption in Recipient CellsAshley E Russell, Sujung Jun, Saumyendra Sarkar, et al.
Cancer Immunology, Immunotherapy : CII|February 17, 2024
Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancerAngisha Basnet, Kaitlyn M Landreth, Remi Nohoesu, et al.
Scientific Reports|August 5, 2021
Co-culture model of B-cell acute lymphoblastic leukemia recapitulates a transcription signature of chemotherapy-refractory minimal residual diseaseStephanie L Rellick, Gangqing Hu, Debra Piktel, et al.
Expert Opinion on Investigational Drugs|June 7, 2012
Curcumin and neurodegenerative diseases: a perspectiveAltaf S Darvesh, Richard T Carroll, Anupam Bishayee, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2004
Molecular modeling studies on the active binding site of the blood-brain barrier choline transporterWerner J Geldenhuys, Paul R Lockman, James H McAfee, et al.
Chembiochem : a European Journal of Chemical Biology|July 22, 2014
Methyl Yellow: A Potential Drug Scaffold for Parkinson's DiseaseWerner J Geldenhuys, Akiko Kochi, Li Lin, et al.
Neurochemical Research|September 22, 2011
Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell typesJ A Lockman, W J Geldenhuys, K A Bohn, et al.
Pageof 18